Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2001 1
2005 1
2007 1
2008 1
2009 2
2013 2
2014 1
2015 2
2016 4
2017 1
2019 2
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Superior vena cava stenting.
Yim CD, Sane SS, Bjarnason H. Yim CD, et al. Radiol Clin North Am. 2000 Mar;38(2):409-24. doi: 10.1016/s0033-8389(05)70171-8. Radiol Clin North Am. 2000. PMID: 10765398 Review.
Stent placement rapidly alleviates the symptoms of SVC syndrome and improves the patient's quality of life. The long-term patency rates have not been established; however, in patients with SVC syndrome secondary to malignant disease, stents usually remain patent for the li …
Stent placement rapidly alleviates the symptoms of SVC syndrome and improves the patient's quality of life. The long-term patency rat …
Current cancer therapies and their influence on glucose control.
Yim C, Mansell K, Hussein N, Arnason T. Yim C, et al. World J Diabetes. 2021 Jul 15;12(7):1010-1025. doi: 10.4239/wjd.v12.i7.1010. World J Diabetes. 2021. PMID: 34326951 Free PMC article. Review.
There are distinct differences in the reversibility of glucose elevations after treatment is stopped, as the mTOR inhibitors and ICI classes have persistent hyperglycemia long term. These four highlighted drug categories differ in their underlying mechanisms driving hyperg …
There are distinct differences in the reversibility of glucose elevations after treatment is stopped, as the mTOR inhibitors and ICI classes …
Understanding hepatitis C.
Yim CK. Yim CK. CANNT J. 2001 Jul-Sep;11(3):24-30, 33-40; quiz 31-2, 41-2. CANNT J. 2001. PMID: 11785189 Review. English, French.
Today, intravenous drug use remains the most common route of transmission. The risk of acquiring HCV infection in patients on long-term hemodialysis is expected to decrease because of the screening of blood products for HCV. ...The current standard of treatment that employ …
Today, intravenous drug use remains the most common route of transmission. The risk of acquiring HCV infection in patients on long-term …
Central Toxic Keratopathy in Siblings After Laser-Assisted Keratomileusis: Case Report and Literature Review.
Yim CK, Zhu D. Yim CK, et al. Cornea. 2022 May 1;41(5):640-643. doi: 10.1097/ICO.0000000000002890. Cornea. 2022. PMID: 35383619 Review.
The siblings were closely followed and treated with a short course of prophylactic topical antibiotics and rapid steroid taper, along with aggressive lubrication and long-term systemic treatment including oral doxycycline, vitamin C, and coenzyme Q10. ...
The siblings were closely followed and treated with a short course of prophylactic topical antibiotics and rapid steroid taper, along with a …
Post-term surveillance and birth outcomes in South Asian-born compared with Australian-born women.
Yim C, Wong L, Cabalag C, Wallace EM, Davies-Tuck M. Yim C, et al. J Perinatol. 2017 Feb;37(2):139-143. doi: 10.1038/jp.2016.190. Epub 2016 Dec 8. J Perinatol. 2017. PMID: 27929532
OBJECTIVE: To determine if apparently healthy post-term South Asian-born (SA) women were more likely to have abnormal post-term fetal surveillance than Australian- and New Zealand-born (AUS/NZ) women, whether those abnormalities were associated with increased rates …
OBJECTIVE: To determine if apparently healthy post-term South Asian-born (SA) women were more likely to have abnormal post-term …
Chemically modulated graphene diodes.
Kim HY, Lee K, McEvoy N, Yim C, Duesberg GS. Kim HY, et al. Among authors: yim c. Nano Lett. 2013 May 8;13(5):2182-8. doi: 10.1021/nl400674k. Epub 2013 Apr 8. Nano Lett. 2013. PMID: 23547771 Free PMC article.
The GDS allows for investigation and tuning of extrinsic doping of graphene with great reliability. The demonstrated recovery and long-term stability qualifies the GDS as a new platform for gas, environmental, and biocompatible sensors....
The GDS allows for investigation and tuning of extrinsic doping of graphene with great reliability. The demonstrated recovery and long-te …
Percutaneous endoscopic gastrostomy using the introducer method with ultra-slim endoscopy in amyotrophic lateral sclerosis patients with respiratory compromise: A safe technique.
Chuah KH, Yim CCW, Abdul Aziz NA, Loh EC, Capelle DP, Shahrizaila N, Leow AHR. Chuah KH, et al. Among authors: yim ccw. J Gastroenterol Hepatol. 2022 Jul;37(7):1367-1372. doi: 10.1111/jgh.15870. Epub 2022 Apr 25. J Gastroenterol Hepatol. 2022. PMID: 35470471
Amongst the PEG cohort, 61% were stratified high risk and 31% moderate risk. Thirty-one percent of them required long-term home noninvasive ventilation. All patients (100%) underwent successful PEG insertion at single attempt using the modified approach. ...
Amongst the PEG cohort, 61% were stratified high risk and 31% moderate risk. Thirty-one percent of them required long-term home nonin …
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
Yhim HY, Lee NR, Song EK, Yim CY, Jeon SY, Lee B, Kim JA, Kim HS, Cho EH, Kwak JY. Yhim HY, et al. Among authors: yim cy. Acta Haematol. 2016;135(3):133-9. doi: 10.1159/000440936. Epub 2015 Nov 5. Acta Haematol. 2016. PMID: 26535871
IM was readministered in all patients with molecular relapse, and 12 patients (86%) reachieved UMRD at a median of 5.3 months. A high-risk Sokal score, delayed UMRD achievement and short-term IM therapy were significantly associated with molecular relapse. CONCLUSION: Thes …
IM was readministered in all patients with molecular relapse, and 12 patients (86%) reachieved UMRD at a median of 5.3 months. A high-risk S …
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).
Liem KS, Fung S, Wong DK, Yim C, Noureldin S, Chen J, Feld JJ, Hansen BE, Janssen HLA. Liem KS, et al. Among authors: yim c. Gut. 2019 Dec;68(12):2206-2213. doi: 10.1136/gutjnl-2019-318981. Epub 2019 Aug 28. Gut. 2019. PMID: 31462554 Clinical Trial.
OBJECTIVE: Although most patients with chronic hepatitis B (CHB) reach effective virological suppression with long-term nucleos(t)ide analogues (NA) therapy, some might not need to continue treatment for life. In this randomised, controlled, phase IV trial, we evaluated of …
OBJECTIVE: Although most patients with chronic hepatitis B (CHB) reach effective virological suppression with long-term nucleos(t)ide …
Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B.
Evon DM, Lin HS, Fontana RJ, Khalili M, Yim C, Wahed AS, Hoofnagle JH. Evon DM, et al. Among authors: yim c. GastroHep. 2021 May;3(3):196-208. doi: 10.1002/ygh2.458. Epub 2021 May 5. GastroHep. 2021. PMID: 34421369 Free PMC article.
Latent class symptom trajectories were evaluated. The cumulative probability of long-term clinical outcomes (new onset cirrhosis, hepatic decompensation, hepatocellular carcinoma, liver transplantation, death) was examined by baseline symptom groups. ...
Latent class symptom trajectories were evaluated. The cumulative probability of long-term clinical outcomes (new onset cirrhosis, hep …
22 results